Attenuation of Venezuelan Equine Encephalitis Virus Strain TC-83 is Encoded by the 5'-noncoding Region and the E2 Envelope Glycoprotein

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 1993 Mar 1

PMID 7679745

Citations 124

Authors

R M Kinney

G J Chang

K R Tsuchiya

J M Sneider

J T Roehrig

T M Woodward

D W TRENT

Affiliations

Soon will be listed here.

Abstract

The virulent Trinidad donkey (TRD) strain of Venezuelan equine encephalitis (VEE) virus and its live attenuated vaccine derivative, TC-83 virus, have different neurovirulence characteristics. A full-length cDNA clone of the TC-83 virus genome was constructed behind the bacteriophage T7 promoter in the polylinker of plasmid pUC18. To identify the genomic determinants of TC-83 virus attenuation, TRD virus-specific sequences were inserted into the TC-83 virus clone by in vitro mutagenesis or recombination. Antigenic analysis of recombinant viruses with VEE E2- and E1-specific monoclonal antibodies gave predicted antigenic reactivities. Mouse challenge experiments indicated that genetic markers responsible for the attenuated phenotype of TC-83 virus are composed of genome nucleotide position 3 in the 5'-noncoding region and the E2 envelope glycoprotein. TC-83 virus amino acid position E2-120 appeared to be the major structural determinant of attenuation. Insertion of the TRD virus-specific 5'-noncoding region, by itself, into the TC-83 virus full-length clone did not alter the attenuated phenotype of the virus. However, the TRD virus-specific 5'-noncoding region enhanced the virulence potential of downstream TRD virus amino acid sequences.

Citing Articles

Old World alphaviruses use distinct mechanisms to infect brain microvascular endothelial cells for neuroinvasion.

Alvarez P, Tang A, Winters D, Kaushal P, Medina A, Kaczor-Urbanowicz K bioRxiv. 2025; .

PMID: 39896450 PMC: 11785202. DOI: 10.1101/2025.01.22.634395.

RNA structures within Venezuelan equine encephalitis virus E1 alter macrophage replication fitness and contribute to viral emergence.

Hickson S, Hyde J PLoS Pathog. 2024; 20(9):e1012179.

PMID: 39331659 PMC: 11463830. DOI: 10.1371/journal.ppat.1012179.

RNA structures within Venezuelan equine encephalitis virus E1 alter macrophage replication fitness and contribute to viral emergence.

Hickson S, Hyde J bioRxiv. 2024; .

PMID: 38645187 PMC: 11030350. DOI: 10.1101/2024.04.09.588743.

Phagocyte-expressed glycosaminoglycans promote capture of alphaviruses from the blood circulation in a host species-specific manner.

Ander S, Parks M, Davenport B, Li F, Bosco-Lauth A, Carpentier K PNAS Nexus. 2024; 3(4):pgae119.

PMID: 38560529 PMC: 10978064. DOI: 10.1093/pnasnexus/pgae119.

Single-Dose Immunogenic DNA Vaccines Coding for Live-Attenuated Alpha- and Flaviviruses.

Pushko P, Lukashevich I, Johnson D, Tretyakova I Viruses. 2024; 16(3).

PMID: 38543793 PMC: 10974764. DOI: 10.3390/v16030428.

References

Gorelkin L . Venezuelan equine encephalomyelitis in an adult animal host. An electron microscopic study. Am J Pathol. 1973; 73(2):425-42. PMC: 1904063. View

Jahrling P, Hilmas D, Heard C . Vascular clearance of venezuelan equine encephalomyelitis viruses as a correlate to virulence for rhesus monkeys. Arch Virol. 1977; 55(1-2):161-4. DOI: 10.1007/BF01314490. View

Mecham J, TRENT D . A biochemical comparison of the in vitro replication of a virulent and an avirulent strain of Venezuelan encephalitis virus. J Gen Virol. 1983; 64(Pt 5):1111-9. DOI: 10.1099/0022-1317-64-5-1111. View

Fu J, Stein S, Rosenstein L, Bodwell T, Routbort M, Semler B . Neurovirulence determinants of genetically engineered Theiler viruses. Proc Natl Acad Sci U S A. 1990; 87(11):4125-9. PMC: 54060. DOI: 10.1073/pnas.87.11.4125. View

Jahrling P, Heisey G, Hesse R . Evaluation of vascular clearance as a marker for virulence of alphaviruses: disassociation of rapid clearance with low virulence of venezuelan encephalitis virus strains in guinea pigs. Infect Immun. 1977; 17(2):356-60. PMC: 421127. DOI: 10.1128/iai.17.2.356-360.1977. View

Vandeyar M, Weiner M, HUTTON C, Batt C . A simple and rapid method for the selection of oligodeoxynucleotide-directed mutants. Gene. 1988; 65(1):129-33. DOI: 10.1016/0378-1119(88)90425-8. View

Kinney R, Johnson B, Brown V, TRENT D . Nucleotide sequence of the 26 S mRNA of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and deduced sequence of the encoded structural proteins. Virology. 1986; 152(2):400-13. DOI: 10.1016/0042-6822(86)90142-x. View

Roehrig J, HUNT A, Kinney R, MATHEWS J . In vitro mechanisms of monoclonal antibody neutralization of alphaviruses. Virology. 1988; 165(1):66-73. DOI: 10.1016/0042-6822(88)90659-9. View

Roehrig J, HUNT A, Johnson A, Hawkes R . Synthetic peptides derived from the deduced amino acid sequence of the E-glycoprotein of Murray Valley encephalitis virus elicit antiviral antibody. Virology. 1989; 171(1):49-60. DOI: 10.1016/0042-6822(89)90509-6. View

10.

Chang G, Johnson B, TRENT D . Site-specific oligonucleotide-directed mutagenesis using T4 DNA polymerase. DNA. 1988; 7(3):211-7. DOI: 10.1089/dna.1988.7.211. View

11.

Omata T, Kohara M, Kuge S, Komatsu T, Abe S, Semler B . Genetic analysis of the attenuation phenotype of poliovirus type 1. J Virol. 1986; 58(2):348-58. PMC: 252919. DOI: 10.1128/JVI.58.2.348-358.1986. View

12.

Fazakerley J, Parker S, BLOOM F, Buchmeier M . The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type-4 is neuroattenuated by its reduced rate of spread in the central nervous system. Virology. 1992; 187(1):178-88. PMC: 7131170. DOI: 10.1016/0042-6822(92)90306-a. View

13.

Mecham J, TRENT D . A comparison of the 26 S mRNAs and structural proteins of an equine virulent venezuelan encephalitis virus and its vaccine derivative. Virology. 1982; 121(2):251-61. DOI: 10.1016/0042-6822(82)90165-9. View

14.

Jahrling P, SCHERER W . Growth curves and clearance rates of virulent and benign Venezuelan encephalitis viruses in hamsters. Infect Immun. 1973; 8(3):456-62. PMC: 422872. DOI: 10.1128/iai.8.3.456-462.1973. View

15.

Atkins G . The avirulent A7 Strain of Semliki Forest virus has reduced cytopathogenicity for neuroblastoma cells compared to the virulent L10 strain. J Gen Virol. 1983; 64 (Pt 6):1401-4. DOI: 10.1099/0022-1317-64-6-1401. View

16.

Davis N, Powell N, Greenwald G, Willis L, Johnson B, Smith J . Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone. Virology. 1991; 183(1):20-31. DOI: 10.1016/0042-6822(91)90114-q. View

17.

MCKINNEY R, BERGE T, SAWYER W, TIGERTT W, Crozier D . USE OF AN ATTENUATED STRAIN OF VENEZUELAN EQUINE ENCEPHALOMYELITIS VIRUS FOR IMMUNIZATION IN MAN. Am J Trop Med Hyg. 1963; 12:597-603. DOI: 10.4269/ajtmh.1963.12.597. View

18.

Dower W, Miller J, Ragsdale C . High efficiency transformation of E. coli by high voltage electroporation. Nucleic Acids Res. 1988; 16(13):6127-45. PMC: 336852. DOI: 10.1093/nar/16.13.6127. View

19.

Kinney R, Johnson B, Welch J, Tsuchiya K, TRENT D . The full-length nucleotide sequences of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and its attenuated vaccine derivative, strain TC-83. Virology. 1989; 170(1):19-30. DOI: 10.1016/0042-6822(89)90347-4. View

20.

Jahrling P, SCHERER W . Homegeneity of Venezuelan encephalitis virion populations of hamster-virulent and benign strains, including the attenuated TC83 vaccine. Infect Immun. 1973; 7(6):905-10. PMC: 422781. DOI: 10.1128/iai.7.6.905-910.1973. View